Nexalin Technology, Inc. (NXL) just unveiled an update.
Michael Nketiah will step down as Nexalin Technology Inc.’s Senior Vice President of Clinical, Quality, & Regulatory Affairs on August 16, 2024, to pursue a new professional opportunity. His departure is amicable, with no disagreements with the company reported. Nketiah will continue his duties until the effective date of his resignation.
For an in-depth examination of NXL stock, go to TipRanks’ Stock Analysis page.